arrow
Back
D

Deborah Finco

pfizer usa

10H-index
25Paper Count
688Citation Count
Published Papers 9
Publication Date
Neutralizing Antibody Validation Testing and Reporting Harmonization
err2023-07-08
err10
errOAAI
errMyler, Heather; Pedras-Vasconcelos, Joao; Lester, Todd; Civoli, Francesca; Xu, Weifeng; Wu, Bonnie; Vainshtein, Inna; Luo, Linlin; Hassanein, Mohamed; Liu, Susana; Ramaswamy, Swarna Suba; Mora, Johanna; Pennucci, Jason; McCush, Fred; Lavelle, Amy; Jani, Darshana; Ambakhutwala, Angela; Baltrukonis, Daniel; Barker, Breann; Carmean, Rebecca; Chung, Shan; Dai, Sheng; DeWall, Stephen; Dholakiya, Sanjay L.; Dodge, Robert; Finco, Deborah; Yan, Haoheng; Hays, Amanda; Hu, Zheng; Inzano, Cynthia; Kamen, Lynn; Lai, Ching-Ha; Meyer, Erik; Nelson, Robert; Paudel, Amrit; Phillips, Kelli; Poupart, Marie-Eve; Qu, Qiang; Abhari, Mohsen Rajabi; Ryding, Janka; Sheldon, Curtis; Spriggs, Franklin; Warrino, Dominic; Wu, Yuling; Yang, Lin; Pasas-Farmer, Stephanie
errShare
errSave
Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody
err2020-03-17
err4
PREAI
errKernstock, Robert; Sperinde, Gizette; Finco, Deborah; Davis, Roslyn; Montgomery, Diana
errShare
errSave
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
err2018-03-30
err66
errOAAI
errGorovits, B.; Baltrukonis, D. J.; Bhattacharya, I; Birchler, M. A.; Finco, D.; Sikkema, D.; Vincent, M. S.; Lula, S.; Marshall, L.; Hickling, T. P.
errShare
errSave
Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions
err2016-09-01
err43
errOAAI
errGrimaldi, Christine; Finco, Deborah; Fort, Madeline M.; Gliddon, Daniel; Harper, Kirsty; Helms, Whitney S.; Mitchell, Jane A.; O'Lone, Raegan; Parish, Stanley T.; Piche, Marie-Soleil; Reed, Daniel M.; Reichmann, Gabriele; Ryan, Patricia C.; Stebbings, Richard; Walker, Mindi
errShare
errSave
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
err2015-07-02
err76
errOAAI
errRup, B.; Pallardy, M.; Sikkema, D.; Albert, T.; Allez, M.; Broet, P.; Carini, C.; Creeke, P.; Davidson, J.; De Vries, N.; Finco, D.; Fogdell-Hahn, A.; Havrdova, E.; Hincelin-Mery, A.; Holland, M. C.; Jensen, P. E. H.; Jury, E. C.; Kirby, H.; Kramer, D.; Lacroix-Desmazes, S.; Legrand, J.; Maggi, E.; Maillere, B.; Mariette, X.; Mauri, C.; Mikol, V.; Mulleman, D.; Oldenburg, J.; Paintaud, G.; Pedersen, C. R.; Ruperto, N.; Seitz, R.; Spindeldreher, S.; Deisenhammer, F.
errShare
errSave
Cytokine release assays: Current practices and future directions
err2014-04-01
err102
PREAI
errFinco, D.; Grimaldi, C.; Fort, M.; Walker, M.; Kiessling, A.; Wolf, B.; Salcedo, T.; Faggioni, R.; Schneider, A.; Ibraghimov, A.; Scesney, S.; Serna, D.; Prell, R.; Stebbings, R.; Narayanan, P. K.
errShare
errSave
Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics
err2011-07-01
err115
PREAI
errGupta, Shalini; Devanarayan, Viswanath; Finco, Deborah; Gunn, George R., III; Kirshner, Susan; Richards, Susan; Rup, Bonita; Song, An; Subramanyam, Meena
errShare
errSave
A multiple-dose toxicity study of tanezumab in cynomolgus monkeys
err2011-03-01
err24
PREAI
errZorbas, Mark; Hurst, Susan; Shelton, David; Evans, Mark; Finco, Deborah; Butt, Mark
errShare
errSave
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics
err2011-01-01
err42
PREAI
errFinco, Deborah; Baltrukonis, Daniel; Clements-Egan, Adrienne; Delaria, Kathy; Gunn, George R., III; Lowe, John; Maia, Mauricio; Wong, Teresa
errShare
errSave